Tech Company Financing Transactions
CureLab Funding Round
Private investors participated in a $3 million funding round for CureLab. The round was announced on 3/2/2023.
Transaction Overview
Company Name
Announced On
3/2/2023
Transaction Type
Venture Equity
Amount
$3,000,000
Round
Undisclosed
Investors
private investors (Lead Investor) (John Ballantyne)
Proceeds Purpose
The funds will enable CureLab Oncology to ramp up toward FDA-monitored clinical trials for triple-negative breast cancer and platinum-resistant ovarian cancer in 2023.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
177 Huntington Ave Fl 17
Boston, MA 02115-3156
USA
Boston, MA 02115-3156
USA
Phone
Website
Email Address
Overview
CureLab Oncology is a biotechnology company that is developing new anti-cancer biologics. CureLab Oncology is committed to creating a family of revolutionary therapies for oncology patients in order to help prolong their lives.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Alexander Shneider
Chief Operating Officer
Charles Legg
VP - R & D
Vlad Gabai
Browse more venture capital transactions:
Prev: 3/2/2023: Edurino venture capital transaction
Next: 3/2/2023: Polyteia venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. All VC database entries reported here are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs